These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34938746)

  • 1. Biologics for Psoriasis During the COVID-19 Pandemic.
    Zeng H; Wang S; Chen L; Shen Z
    Front Med (Lausanne); 2021; 8():759568. PubMed ID: 34938746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Brownstone ND; Thibodeaux QG; Reddy VD; Myers BA; Chan SY; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):881-885. PubMed ID: 32468230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis.
    Gisondi P; Geat D; Bellinato F; Girolomoni G
    Expert Opin Biol Ther; 2022 Dec; 22(12):1521-1529. PubMed ID: 35930356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: A real life experience.
    Musumeci ML; Caruso G; Trecarichi AC; Micali G
    Dermatol Ther; 2022 Jan; 35(1):e15177. PubMed ID: 34699117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
    Brownstone ND; Thibodeaux QG; Reddy VD; Myers BA; Chan SY; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2020 Jun; 10(3):339-349. PubMed ID: 32300516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for Psoriasis during the COVID-19 Pandemic.
    Kamiya K; Komine M; Ohtsuki M
    J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33808455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.
    Kado S; Kamiya K; Kishimoto M; Maekawa T; Kuwahara A; Sugai J; Komine M; Ohtsuki M
    J Dermatol; 2021 Dec; 48(12):1907-1912. PubMed ID: 34549456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BIOLOGICAL TREATMENT OF PSORIASIS IN TIME OF NEW CORONAVIRUS INFECTION COVID-19].
    Kruglova LS; Pereverzina NO; Rudneva NS; Kamynina NN; Oynotkinova OS
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1381-1387. PubMed ID: 34792893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and psoriasis: biologic treatment and challenges.
    Ebrahimi A; Sayad B; Rahimi Z
    J Dermatolog Treat; 2022 Mar; 33(2):699-703. PubMed ID: 32598204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.
    Campanati A; Diotallevi F; Martina E; Radi G; Offidani A
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does COVID-19 impact psoriasis practice, prescription patterns, and healthcare delivery for psoriasis patients? A cross-sectional survey study.
    El-Komy MHM; Abdelnaby A; El-Kalioby M
    J Cosmet Dermatol; 2021 Jun; 20(6):1573-1579. PubMed ID: 33811728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID).
    Kwee KV; Murk JL; Yin Q; Visch MB; Davidson L; de Jong EMGJ; van den Reek JMPA; Tjioe M
    J Dermatolog Treat; 2023 Dec; 34(1):2161297. PubMed ID: 36545844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
    Bragazzi NL; Riccò M; Pacifico A; Malagoli P; Kridin K; Pigatto P; Damiani G
    Dermatol Ther; 2020 Jul; 33(4):e13508. PubMed ID: 32415727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis, biologic therapy, and the pandemic of the 21st century.
    Nogueira M; Vender R; Torres T
    Drugs Context; 2020; 9():. PubMed ID: 32477419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.
    Samotij D; Gawron E; Szczęch J; Ostańska E; Reich A
    Biologics; 2021; 15():107-113. PubMed ID: 33948082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and COVID-19: A narrative review with treatment considerations.
    Elmas ÖF; Demirbaş A; Kutlu Ö; Bağcıer F; Metin MS; Özyurt K; Akdeniz N; Atasoy M; Türsen Ü; Lotti T
    Dermatol Ther; 2020 Nov; 33(6):e13858. PubMed ID: 32686245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.
    Sadeghinia A; Daneshpazhooh M
    Dermatol Ther; 2021 Jan; 34(1):e14498. PubMed ID: 33141519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.